<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>High-dose <z:chebi fb="14" ids="27306">vitamin B6</z:chebi> (<z:chebi fb="5" ids="16709">pyridoxine</z:chebi>-HCl, 300 mg/kg/day orally) was introduced as the initial treatment of recently manifested <z:e sem="disease" ids="C0037769" disease_type="Disease or Syndrome" abbrv="">infantile spasms</z:e> in 17 children (13 symptomatic cases with identified brain lesion and 4 cryptogenic cases) </plain></SENT>
<SENT sid="1" pm="."><plain>5 of 17 children (2 cryptogenic, 2 with severe pre/<z:e sem="disease" ids="C0852862" disease_type="Disease or Syndrome" abbrv="">perinatal brain damage</z:e> and one with <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber syndrome</z:e>) were classified as responders to high-dose <z:chebi fb="14" ids="27306">vitamin B6</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> 5 cases the response to <z:chebi fb="14" ids="27306">vitamin B6</z:chebi> occurred within the first 2 weeks of treatment and within 4 weeks <z:hpo ids='HP_0000001'>all</z:hpo> patients were free of <z:hpo ids='HP_0001250'>seizures</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Two patients developed other <z:hpo ids='HP_0001250'>seizures</z:hpo> (<z:hpo ids='HP_0007359'>partial seizures</z:hpo>, etiologically unclear blinking attacks), but no relapse of <z:e sem="disease" ids="C0037769" disease_type="Disease or Syndrome" abbrv="">infantile spasms</z:e> was observed among the five responders to <z:chebi fb="14" ids="27306">vitamin B6</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>No serious adverse reactions were noted </plain></SENT>
<SENT sid="5" pm="."><plain>Side effects were mainly gastrointestinal symptoms, which were reversible after reduction of the dosage </plain></SENT>
<SENT sid="6" pm="."><plain>Considering the life-threatening side effects of treatment with ACTH/<z:chebi fb="0" ids="50858">corticosteroids</z:chebi> or valproate, a controlled clinical trial with high-dose <z:chebi fb="14" ids="27306">vitamin B6</z:chebi> would appear justified to either prove or disprove efficacy </plain></SENT>
</text></document>